Polymeric Nanoparticles Applied to Therapy and Diagnostics
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 December 2021) | Viewed by 346
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanotechnology has grown prominent in the field of biomedicine by circumventing some deficiencies of current treatments. Nanotechnology approaches protect the active drug from the instabilities of body compartments and drive the drug into the pharmacological targets, reducing adverse effects. Polymeric nanoparticles (PNPs) comprise nanocapsules and nanospheres, highly employed as drug delivery or diagnostic tools. Nanocapsules carry the active molecules, mainly dissolved in an oily core surrounded by a polymeric shell, while nanospheres present a continuous polymeric network in which the active molecule can be retained inside or adsorbed onto their surface. They can be produced in fast processes that can be scaled up, and huge amounts of pre-clinical studies have shown the effectiveness of PNPs in a diversity of experimental models of diseases. This Special Issue aims to highlight pre-clinical studies and translational application of PNPs such as drug-delivery or diagnostics tools. We invite articles on these aspects of PNPs applications, focusing on the most suitable experimental approaches, routes of administrations, toxic effects and on advances on clinical trials to acute and chronic diseases.
Prof. Dr. Sandra Farsky
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanopharmacology
- nanotoxicology
- nanotechnology
- drug delivery
- bioavailability
- theranostic
- inflammatory based diseases
- cancer
- tissue repair
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
